Tchaikapharma High Quality Medicines AD (BUL:THQM)

BUL:THQM Cash Flow Statement

Financials in millions BGN. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	4.49	3.4	2.79	1.4	0.43
Depreciation & Amortization	2.5	2.8	3.54	3.85	4.23
Other Amortization	0.02	0.01	0.03	0.03	-
Other Operating Activities	-3.65	-3.34	-3.9	-3.25	-1.17
Operating Cash Flow	3.37	2.87	2.46	2.02	3.49
Operating Cash Flow Growth	17.37%	16.50%	21.65%	-41.97%	56.75%
Capital Expenditures	-2.17	-1.91	-1.58	-1.57	-2.91
Other Investing Activities	-0.05	-	-	-	-
Investing Cash Flow	-2.22	-1.91	-1.58	-1.57	-2.91
Short-Term Debt Issued	-	-	0.25	0.2	0.2
Total Debt Issued	-	-	0.25	0.2	0.2
Short-Term Debt Repaid	-	-	-0.25	-0.2	-0.2
Long-Term Debt Repaid	-0.53	-0.52	-0.52	-0.46	-0.36
Total Debt Repaid	-0.53	-0.52	-0.77	-0.66	-0.56
Net Debt Issued (Repaid)	-0.53	-0.52	-0.52	-0.46	-0.36
Other Financing Activities	-0.6	-0.5	-0.27	0	-0.2
Financing Cash Flow	-1.13	-1.02	-0.8	-0.46	-0.56
Net Cash Flow	0.02	-0.07	0.09	-0.01	0.02
Free Cash Flow	1.2	0.96	0.88	0.45	0.58
Free Cash Flow Growth	25.34%	8.40%	95.78%	-22.28%	-45.07%
Free Cash Flow Margin	2.25%	1.97%	2.04%	1.06%	1.44%
Free Cash Flow Per Share	0.01	0.01	0.01	0.01	0.01
Cash Interest Paid	0.6	0.5	0.27	0.2	0.2
Cash Income Tax Paid	0.57	0.39	0.45	0.22	0.35
Levered Free Cash Flow	-1.28	-2.41	-0.97	1.57	12.74
Unlevered Free Cash Flow	-0.91	-2.07	-0.8	1.74	12.89
Change in Net Working Capital	4.56	5.47	4.69	1.48	-11.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.